NEW YORK (Reuters Health) – Specialists at McGill University in Montreal have developed a fertility preservation protocol of immature oocyte retrieval, in vitro maturation, vitrification of the mature…
NEW YORK (Reuters Health) – In those relatively rare “slow-progressing” HIV-infected patients who mount an effective immune response to the infection, the neutralizing activity is made up of…
NEW YORK (Reuters Health) – Although the incidence of health care-associated Clostridium difficile infections remained stable in Canada between 1997 and 2005, the attributable mortality nearly quadrupled, according…
Organic chemist professor Edward Biehl PhD , Professor and Chair, Department of Chemistry, Southern Methodist University, discusses the discovery of a new compound that aims to prevent neurodegeneration…
NEW YORK (Reuters Health) – The seroprevalence of Coxiella burnetii – the causative organism of the zoonotic disease Q-fever – is high among US veterinarians, particularly those who…
NEW YORK (Reuters Health) – Mesenchymal stem cell allografts can promote bone healing in patients who have failed foot and ankle surgery and are at high risk for…
NEW YORK (Reuters Health) – Although it is safe, low-dose vitamin K used to treat warfarin recipients with high INRs (international normalized ratios) does not reduce episodes of…
NEW YORK (Reuters Health) – In a phase I trial involving patients with advanced squamous cell carcinoma of the head and neck (SCCHN), direct intratumoral injection of epithelial…
NEW YORK (Reuters Health) – US researchers have identified 10 antibodies that provide broad-spectrum neutralization of human and avian influenza A viruses. The researchers report their findings in…
NEW YORK (Reuters Health) – Yearly gynecological examinations fail to identify early stage ovarian cancer in women with a mutation in the BRCA1 or BRCA2 gene, a Dutch…